MKI67 and neoplasm: Cancer recurrence is no longer synonymous with clinical high-risk such as bigger tumors, higher grade or node positivity, or high proliferative marker (Ki67). Underlying complex tumor biology is of paramount importance and gives a true assessment of recurrence risk [22].